PLx Pharma Inc. (PLXP) financial statements (2021 and earlier)

Company profile

Business Address 9 FISHERS LANE
SPARTA, NJ 07871
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:141424173227
Cash and cash equivalents14142417527
Short-term investments    27 
Other undisclosed cash, cash equivalents, and short-term investments   0(0) 
Receivables000   
Inventory, net of allowances, customer advances and progress billings(1)(1)0   
Inventory(1)(1)0   
Prepaid expense 00000
Deferred costs 0    
Deposits current assets  0   
Other undisclosed current assets111(0)0 
Total current assets:141526173227
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment111   
Intangible assets, net (including goodwill), including:222   
Goodwill222   
Intangible assets, net (excluding goodwill)  2   
Other undisclosed intangible assets, net (including goodwill)  (2)   
Deposits noncurrent assets000   
Other noncurrent assets   000
Total noncurrent assets:443000
TOTAL ASSETS:191829173227
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:111221
Accrued liabilities   100
Employee-related liabilities   111
Interest and dividends payable00    
Other undisclosed accounts payable and accrued liabilities111111
Debt43    
Other liabilities000   
Other undisclosed current liabilities111   
Total current liabilities:652221
Noncurrent Liabilities
Long-term debt and lease obligation147   
Long-term debt, excluding current maturities147   
Liabilities, other than long-term debt9315   
Other liabilities000   
Derivative instruments and hedges, liabilities8315   
Other undisclosed noncurrent liabilities200   
Total noncurrent liabilities:11722   
Total liabilities:171224221
Stockholders' equity
Stockholders' equity attributable to parent(12)65153126
Common stock000000
Additional paid in capital757372777248
Accumulated deficit(87)(66)(67)(62)(41)(22)
Other undisclosed stockholders' equity14     
Total stockholders' equity:265153126
TOTAL LIABILITIES AND EQUITY:191829173227

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues111   
Revenue, net1   
Sublease income0
Cost of revenue
(Cost of Goods and Services Sold)
 (1)(0)   
Gross profit:1(0)0   
Operating expenses(15)(12)(17)(21)(19)(14)
Other undisclosed operating income 10   
Operating loss:(14)(11)(16)(21)(19)(14)
Nonoperating income (expense)012(0)   
Investment income, nonoperating000   
Interest and debt expense(1)(1)(1)   
Loss from continuing operations before equity method investments, income taxes:(15)(0)(17)(21)(19)(14)
Other undisclosed income (loss) from continuing operations before income taxes(6)11   
Income (loss) from continuing operations before income taxes:(21)1(16)(21)(19)(14)
Income tax expense (benefit)(9)(2)1   
Net loss:(29)(1)(15)(21)(19)(14)
Other undisclosed net income attributable to parent92 00 
Net income (loss) attributable to parent:(21)1(15)(21)(19)(14)
Preferred stock dividends and other adjustments(14)     
Net income (loss) available to common stockholders, diluted:(34)1(15)(21)(19)(14)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(29)(1)(15)(21)(19)(14)
Comprehensive loss, net of tax, attributable to parent:(29)(1)(15)(21)(19)(14)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: